Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for January 20th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 20th:

CF Industries Holdings, Inc. (CF - Free Report) : This manufacturer and distributor of nitrogen fertilizers and other nitrogen products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 27.3% over the last 60 days.

 

CF Industries’ shares gained 19.8% over the last one month compared with the S&P 500’s growth of 2.4%. The company possesses a Momentum Score of A.

 

Navient Corporation (NAVI - Free Report) : This provider of education loan management and business processing solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.

 

Navient’s shares gained 20.6% over the last one month. The company possesses a Momentum Score of A.

 

The Goldman Sachs Group, Inc. (GS - Free Report) : This investment banking, securities, and investment management company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.5% over the last 60 days.

 

Goldman Sachs’ shares gained 21.5% over the last one month. The company possesses a Momentum Score of A.

 

Abercrombie & Fitch Co. (ANF - Free Report) : This specialty retailer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 42.5% over the last 60 days.

 

Abercrombie & Fitch’s shares gained 17.9% over the last one month. The company possesses a Momentum Score of A.

 

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>